Ziprasidone formulations
AssigneeBeloteca, Inc.
InventorsFrederik Defesche, Dorla Mirejovsky, Cristiane Marcondes Messora Barion
Life of this patent
Estimating the term…
Abstract
Provided is an aqueous formulation of ziprasidone, stored for up to six months at 40° C., suitable for intramuscular injection. In these embodiments, the aqueous formulation (a) provides greater than 98% purity of the ziprasidone and/or (b) has less than 0.5% of USP Related Compound C with respect to ziprasidone. Also provided is a method of administering ziprasidone to a patient, the method comprising administering the above formulation to the patient intramuscularly through a syringe.
Claims20
An aqueous formulation that contains a psychotropic effective amount ziprasidone or a pharmaceutically acceptable salt and/or hydrate thereof, being suitable for intramuscular injection, wherein the aqueous formulation when stored at 20-25° C. for 12 months:
- (a) provides greater than 98% purity of the ziprasidone, its pharmaceutically acceptable salt and/or hydrate;
- and
- (b) has less than 0.5% of USP Related Compound C with respect to ziprasidone itself.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.